Top Markets
Coin of the day
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Pozycja w akcjach #38646
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Cena akcji
$0.09
Ostatnia synchronizacja: 2026-07-28
Kapitalizacja rynkowa
$876.21K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-97.79%
Kraj
US
Handel BNB Plus Corp. (BNBX)

Kategoria

Historia ceny akcji dla BNB Plus Corp. (BNBX)
Najwyższa cena zamknięcia: $0.20 dnia 2026-07-01

Najniższa cena zamknięcia: $3.96M dnia 2006-06-01
Historia cen akcji firmy BNB Plus Corp. od 2006 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -32.54%
2025 -98.22%
2024 -98.74%
2023 -46.39%
2022 -71.32%
2021 -19.55%
2020 50.29%
2019 -86.89%
2018 -63.54%
2017 2.62%
2016 -37.30%
2015 17.11%
2014 -59.86%
2013 -10.26%
2012 95.00%
2011 22.22%
2010 -26.83%
2009 74.47%
2008 -60.62%
2007 24.71%
2006 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$507.32 29.98%
US
$848.39 30.04%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE